GMED(GMED)
GMED
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $3.20B | $3.40B | $3.63B | $4.01B | $4.33B |
| Low | $3.19B | $3.36B | $3.63B | $3.98B | $4.30B |
| High | $3.21B | $3.43B | $3.63B | $4.05B | $4.37B |
| EBITDA Avg | $789M | $838M | $894M | $988M | $1.07B |
| Low | $786M | $829M | $894M | $981M | $1.06B |
| High | $791M | $846M | $894M | $998M | $1.08B |
| EBIT Avg | $549M | $584M | $623M | $688M | $743M |
| Low | $548M | $577M | $623M | $683M | $738M |
| High | $551M | $589M | $623M | $695M | $750M |
| Net Income Avg | $650M | $703M | $788M | $904M | $1.02B |
| Low | $648M | $664M | $750M | $896M | $1.01B |
| High | $652M | $741M | $825M | $916M | $1.04B |
| EPS Avg | $4.74 | $5.15 | $5.69 | $6.59 | $7.46 |
| Low | $4.72 | $4.84 | $5.47 | $6.53 | $7.39 |
| High | $4.75 | $5.40 | $6.01 | $6.67 | $7.56 |
| Analysts (Rev / EPS) | 10 / 8 | 10 / 8 | 9 / 5 | 4 / 1 | 4 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $797M | $863M | $796M | $831M | $849M | $920M | $854M | $866M |
| Low | $795M | $855M | $788M | $822M | $840M | $911M | $845M | $857M |
| High | $798M | $870M | $802M | $837M | $855M | $928M | $861M | $873M |
| EBITDA Avg | $196M | $213M | $196M | $205M | $209M | $227M | $210M | $213M |
| Low | $196M | $210M | $194M | $202M | $207M | $224M | $208M | $211M |
| High | $197M | $214M | $198M | $206M | $211M | $228M | $212M | $215M |
| EBIT Avg | $137M | $148M | $137M | $143M | $146M | $158M | $146M | $149M |
| Low | $136M | $147M | $135M | $141M | $144M | $156M | $145M | $147M |
| High | $137M | $149M | $138M | $144M | $147M | $159M | $148M | $150M |
| Net Income Avg | $161M | $188M | $163M | $170M | $176M | $198M | $175M | $186M |
| Low | $160M | $185M | $161M | $168M | $173M | $195M | $173M | $183M |
| High | $164M | $190M | $165M | $172M | $178M | $200M | $177M | $188M |
| EPS Avg | $1.17 | $1.36 | $1.18 | $1.23 | $1.27 | $1.43 | $1.27 | $1.34 |
| Low | $1.16 | $1.34 | $1.17 | $1.21 | $1.25 | $1.41 | $1.25 | $1.33 |
| High | $1.19 | $1.37 | $1.20 | $1.24 | $1.29 | $1.45 | $1.28 | $1.36 |
| Analysts (Rev / EPS) | 8 / 8 | 7 / 6 | 4 / 3 | 6 / 5 | 4 / 3 | 7 / 6 | 3 / 4 | 5 / 6 |